Left Ventricular Dysfunction in Heart Transplant Recipients
📧 Sign up to get email alerts when something new happens for Left Ventricular Dysfunction in Heart Transplant Recipients.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-05-03Clinical Trial Update: The De-novo Use of Eculizumab in Presensitized Patients Receiving Cardiac Transplantation [Phase 3]
Phase 3 trial evaluating de-novo use of eculizumab in presensitized cardiac transplant patients completed; results posted in 2021.